Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics

Creates Pathway for Beneficiary Access to KidneyIntelX for Medicare Beneficiary Kidney Disease Populations Creates Pathway for Beneficiary Access to KidneyIntelX for Medicare Beneficiary Kidney Disease Populations Published on : http://www.globenewswire.com/news-release/2021/01/13/2157588/0/en/Renalytix-Commends-HHS-CMS-on-Finalization-of-MCIT-Rule-to-Provide-National-Medicare-Coverage-for-FDA-Breakthrough-Devices-and-Diagnostics.html…

More